Veterinarian Access
Reconcile product package
Share
FacebookTwitter

About Us
The Elanco/Lilly Legacies

Elanco is a global, innovation-driven company that develops and markets products to improve animal health production in more than 75 countries. Elanco Companion Animal Health enables veterinarians to help pets live longer, healthier, higher quality lives. More information is available at elancopet.com and elanco.com.

Eli Lilly and Company is a leading innovation-driven corporation committed to developing a growing portfolio of first-in-class and best-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions.

How to Reach Us

Product Information and General Inquiries

For information about Reconcile® (fluoxetine hydrochloride) contact us at:
1 (888) 545-5973.

Media contacts

If you are a member of the media seeking more information, please contact:
Colleen Parr Dekker at 1 (317) 276-4076
Global Media Relations and Communications

IMPORTANT SAFETY INFORMATION

The most common adverse events reported in decreasing order of reported frequency are: decreased appetite, depression/lethargy, shaking/shivering/tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, mydriasis, vocalization, weight loss, panting, confusion, incoordination, and hypersalivation.

Reconcile chewable tablets are contraindicated for dogs with epilepsy or a history of seizures; with drugs that lower the seizure threshold; with a monoamine oxidase inhibitor (MAOI) or within a minimum of 14 days of discontinuing therapy with an MAOI; in dogs with a known hypersensitivity to fluoxetine HCl or other SSRIs.

A six—week washout interval should be observed following discontinuation of therapy with Reconcile chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine.

View full product label for complete safety information.

© 2011 Copyright Elanco | Privacy Statement | Trademark | Terms of Use | Site Map